Technically Speakin...
Health Care: Drugs
Biosante Pharmaceuticals Inc. (BPAX: NASDAQ)
$2.22 -0.09 | -3.90%
06/04/12 - 11:29 AM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -51.61M | -46.20M | -47.53M | -17.42M |
| Operating Gains/Losses | 367.50K | 4.58K | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 64.64K | 285.84K | -215.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 134.10K | 3.14M | -1.55M | 2.19M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | -9.00K |
| Other Non-Cash Items | 1.41M | 3.15M | 30.54M | 1.21M |
| Net Cash From Continuing Operations | -47.87M | -40.10M | -18.43M | -15.54M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -47.87M | -40.10M | -18.43M | -15.54M |
| Sale of Property, Plant & Equipment | 0.00 | 3.08K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 3.03M | 11.98M |
| Purchases of Property, Plant & Equipment | -719.92K | -63.44K | -165.72K | -651.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -719.92K | -60.37K | 2.86M | 11.33M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 68.89M | 48.45M | 11.35M | 0.00 |
| Repayment of Long-Term Debt | -1.23M | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 22.32M | 319.00K |
| Net Cash From Financing Activities | 67.66M | 48.45M | 33.67M | 319.00K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 19.07M | 8.30M | 18.10M | -3.89M |
Portfolios with BPAX
- Portfolio NameUser Type
- UserSaveyn walter
- User2012_03
- Userwayne120
- ContributorBreakout Stocks Of The Week...
- UserDunDon1
- Contributor6 Drug Stocks Unworthy of B...
- Contributor3 Small-Cap Stocks on Insid...
- Contributor13 Biotech Stocks Bought an...
- UserSMITTY
- Contributor10 Most Shorted Stocks in B...
Latest BPAX Headlines from TheStreet
- Biosante Stock Gaps Down On Today's Open (BPAX) 06.01.12 | 09:06 am
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Transocean, Netflix, BioSante Are Market Movers 02.27.12 | 05:02 pm
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- Biosante Stock Falls On Unusually High Volume (BPAX) 02.07.12 | 11:02 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Market Preview: The Year Without a Santa Claus Rally 12.14.11 | 08:12 pm
- Novellus, BioSante: After-Hours Trading 12.14.11 | 07:12 pm
Press Releases for BPAX
- BioSante Pharmaceuticals, Inc. To Present At Jefferies Global Healthcare Conference - Business Wire 06.04.12 | 07:06 am
- BioSante Pharmaceuticals Announces Reverse Stock Split In Order To Maintain NASDAQ Listing - Business Wire 05.31.12 | 08:05 pm
- BioSante Pharmaceuticals Reports First Quarter Financial Results - Business Wire 05.08.12 | 04:05 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - PR Newswire 04.04.12 | 05:04 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.03.12 | 02:04 pm
- BioSante Pharmaceuticals Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of BioSante Pharmaceuticals, Inc. - Business Wire 03.29.12 | 05:03 pm
- BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation - Business Wire 03.20.12 | 07:03 am
- BioSante Pharmaceuticals Reports Financial Results For 2011 And Corporate Highlights - Business Wire 03.13.12 | 05:03 pm
- BioSante Pharmaceuticals, Inc. To Present At Roth Health Care Conference - Business Wire 03.09.12 | 07:03 am
- BioSante’s Prostate Cancer Vaccine Resulted In Stable Disease In Over 50% Of Patients In Newly Published Study - Business Wire 03.05.12 | 07:03 am
Partner Headlines for BPAX
- Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha 03.26.12 | 09:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- What BioSante's Balance Sheet Says About Future R&D - Seeking Alpha 03.01.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Singular Research Drops Coverage on BioSante Pharma After LibGel Results - Benzinga 12.16.11 | 04:12 pm
- Singular Research Reiterates BioSante Pharmaceuticals Buy, Maintains PT - Benzinga 12.13.11 | 01:12 pm
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
